2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 142 filers reported holding 2SEVENTY BIO INC in Q3 2023. The put-call ratio across all filers is 3.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,927,867 | -54.4% | 1,002,007 | +17.6% | 1.56% | -40.5% |
| Q2 2023 | $8,622,311 | -1.1% | 852,007 | -0.4% | 2.62% | +13.0% |
| Q1 2023 | $8,721,000 | +179.3% | 855,000 | +156.6% | 2.32% | +178.2% |
| Q4 2022 | $3,122,571 | -59.5% | 333,252 | -37.1% | 0.83% | -59.9% |
| Q3 2022 | $7,715,000 | -28.7% | 530,223 | -35.3% | 2.07% | -49.8% |
| Q2 2022 | $10,820,000 | -22.6% | 819,672 | 0.0% | 4.13% | -30.5% |
| Q1 2022 | $13,984,000 | – | 819,672 | – | 5.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 1,587,805 | $27,088,000 | 6.49% |
| CHI Advisors LLC | 819,672 | $13,984,000 | 5.95% |
| Madison Avenue Partners, LP | 896,972 | $15,302,342,000 | 2.86% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $24,036,000 | 2.33% |
| EcoR1 Capital, LLC | 3,495,943 | $59,641,000 | 1.87% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $5,118,000 | 1.02% |
| CVI Holdings, LLC | 819,672 | $13,984,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 2,000,000 | $34,120,000 | 0.66% |
| Altium Capital Management LP | 115,000 | $1,962,000 | 0.66% |
| Casdin Capital, LLC | 614,754 | $10,488,000 | 0.47% |